Clinical Trials Directory

Trials / Unknown

UnknownNCT00131001

CARMEDAS: Cost-Effectiveness Analysis of Imaging Strategies in Symptomatic Carotid Stenosis

Cost-Effectiveness Analysis of Imaging Strategies in Symptomatic Carotid Stenosis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (planned)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

PURPOSE: The purpose of this clinical trial is to study the cost-effectiveness ratios of diagnostic strategies for the imaging assessment of symptomatic carotid stenosis. MATERIALS AND METHODS: The diagnostic accuracies of Doppler ultrasound (DUS), contrast-enhanced magnetic resonance angiography (CEMRA) and computed tomography angiography (CTA) were compared with digital subtraction angiography (DSA) in a multicenter study (CARMEDAS; 206 patients assessable) and in a meta-analysis (for CEMRA and CTA). The direct costs of each imaging method were calculated in 2 university medical centers. Eight hypothetical models were studied with DUS considered as the first-line imaging method and either CEMRA or CTA or DSA as the second or third line method. The effectiveness criterion was the number of potential avoided strokes for each strategy and for 1000 patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREcontrast-enhanced magnetic resonance angiography

Timeline

Start date
2001-04-01
First posted
2005-08-17
Last updated
2008-10-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00131001. Inclusion in this directory is not an endorsement.